Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0632, USA.
Psychopharmacology (Berl). 2012 Jan;219(1):123-35. doi: 10.1007/s00213-011-2382-5. Epub 2011 Jun 24.
Dopamine D(2)-like agonists maintain responding when substituted for cocaine in laboratory animals. However, these effects appear to be mediated by an interaction with stimuli that were previously paired with cocaine reinforcement (CS).
To evaluate the extent to which the pramipexole-maintained and pramipexole-induced responding are influenced by cocaine-paired stimuli.
Rats were trained to nosepoke for cocaine under fixed ratio 1 (FR1) or progressive ratio (PR) schedules of reinforcement. In FR1-trained rats, pramipexole was substituted for cocaine with injections either paired with CSs, or delivered in their absence. The capacity of experimenter-administered pramipexole to induce FR1 and PR responding for CS presentation was evaluated. The effects of altering stimulus conditions, as well as pretreatments with D(2)- (L: -741,626) and D(3)-preferring (PG01037) antagonists on pramipexole-induced PR responding were also evaluated.
When substituted for cocaine, pramipexole maintained responding at high rates when injections were paired with CSs, but low rates when CSs were omitted. Similarly, experimenter-administered pramipexole induced dose-dependent increases in FR1 or PR responding, with high rates of responding observed when the CS was presented, and low rates of responding when CS presentation was omitted. D(2) and D(3) antagonists differentially affected pramipexole-induced PR responding, with L: -741,626 and PG01037 producing rightward, and downward shifts in the dose-response curve for CS-maintained responding, respectively.
These data indicate that pramipexole is capable of enhancing the reinforcing effectiveness of conditioned stimuli, and raise the possibility that similar mechanisms are responsible for the increased occurrence of impulse control disorders in patients being treated with pramipexole.
在实验室动物中,多巴胺 D2 样激动剂在取代可卡因时可以维持反应。然而,这些作用似乎是通过与之前与可卡因强化(CS)配对的刺激相互作用介导的。
评估普拉克索维持和普拉克索诱导的反应在多大程度上受到可卡因配对刺激的影响。
大鼠接受训练,在固定比率 1(FR1)或递增比率(PR)强化方案下用鼻触可卡因。在 FR1 训练的大鼠中,用注射物替代可卡因,注射物与 CS 配对或在没有 CS 的情况下给药。评估实验者给予的普拉克索在 CS 呈现时诱导 FR1 和 PR 反应的能力。还评估了改变刺激条件以及预先用 D2-(L:-741,626)和 D3-偏好(PG01037)拮抗剂预处理对普拉克索诱导的 PR 反应的影响。
当替代可卡因时,当注射物与 CS 配对时,普拉克索以高反应率维持反应,但当 CS 被省略时,反应率则较低。同样,实验者给予的普拉克索诱导剂量依赖性地增加 FR1 或 PR 反应,当呈现 CS 时观察到高反应率,当省略 CS 呈现时则观察到低反应率。D2 和 D3 拮抗剂对普拉克索诱导的 PR 反应产生不同的影响,L:-741,626 和 PG01037 分别使 CS 维持反应的剂量-反应曲线向右和向下移动。
这些数据表明,普拉克索能够增强条件刺激的强化效果,并提出了类似的机制可能负责接受普拉克索治疗的患者冲动控制障碍发生率增加的可能性。